7251 - 7260 of 9145 Results
Title
Year
-
OPENTitle: Impact of Y chromosome loss on the risk of Parkinson's disease and progressionJournal Name: eBioMedicinePublisher: Elsevier BVVol: 117Issue #:Start Page: 105769End Page: 105769Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769Best OA location URL: https://www.thelancet.com/action/showPdf?pii=S2352396425002130Citation Count: 4
-
OPENTitle: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page: e70078End Page: e70078Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.70078Best OA location URL: https://doi.org/10.1002/alz.70078Citation Count: 6
-
OPENTitle: Cognitive impairment and dementia in Latin American individuals with parkinsonism and Parkinson's disease: A 10/66 Dementia Research Group studyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 7Start Page: e70371End Page: e70371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70371Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70371Citation Count: 1
-
OPENTitle: Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 6Start Page: e70377End Page: e70377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70377Citation Count: 7
-
OPENTitle: Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease: The FIRE-UP PD studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 144Issue #:Start Page: 107619End Page: 107619Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2024.107619Best OA location URL: https://doi.org/10.1016/j.cct.2024.107619Citation Count: 8
- LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits2020RESTRICTEDTitle: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 540Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820Citation Count: 131
-
OPENTitle: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s diseaseJournal Name: Journal of Medical GeneticsPublisher: BMJVol: 57Issue #: 5Start Page: 331End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8474559Citation Count: 71
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 170End Page: 170Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://www.nature.com/articles/s41531-022-00410-y.pdfCitation Count: 320
-
OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page: e112006End Page: e112006Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 35
-
OPENTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1064057End Page: 1064057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 17